Aethlon Medical Inc (NAS:AEMD)
$ 0.5859 0.0358 (6.51%) Market Cap: 2.98 Mil Enterprise Value: -3.99 Mil PE Ratio: 0 PB Ratio: 0.20 GF Score: 51/100

Aethlon Medical Inc at LD Micro Invitational Conference Transcript

Jun 07, 2023 / 08:30PM GMT
Release Date Price: $3.55 (+6.70%)
Unidentified Participant

Okay. Getting settled in, ready for our next presentation with Aethlon Medical. I'd like to introduce to you, Mr. Jim Frakes.

Jim Frakes
Aethlon Medical, Inc. - CFO & SVP, Finance

Thank you very much. Thanks for coming, everyone. I'll let you read our forward-looking statement at your convenience.

A few investment highlights on Aethlon. We're focused on combating cancer and infectious diseases with development of first-in-class immunotherapy therapeutic technologies. We're led by a seasoned industry -- group of industry executives with extensive development and commercialization experience.

Our product, the Hemopurifier, has demonstrated the capture of disease promoting exosomes and circulating viruses in clinical trials and emergency use. And the Hemopurifier has been designated as a Breakthrough Device by the US FDA for two indications. We're well capitalized with a solid cash position.

Now I'd like to introduce my colleague, Guy Cipriani, the Chief Business Officer of Aethlon, to take you through the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot